Aptar Pharma Showcases Next Generation of Integrated Connected Devices at RDD


Aptar Pharma Showcases Next Generation of Integrated Connected Devices at RDD


Aptar_Pharma_Logo150x106

Press Release | Aptar Pharma

APRIL 09, 2018

Crystal Lake, Illinois: – Aptar Pharma, a leading global solution provider of innovative drug delivery systems, is pleased to be a Platinum Sponsor at RDD 2018, taking place from April 22 to April 26 at the JW Marriott Starr Pass Resort and Spa, Tucson, Arizona.

The RDD conference series is recognized as one of the premier international meetings in the respiratory field, impacting regulatory and scientific policies worldwide. As part of the Platinum Sponsor Seminars at RDD 2018, Aptar Pharma experts will present a 40-minute talk on the most recent FDA guidance on Combination Products, with a focus on respiratory and nasal drug products. The seminar, entitled “Decoding FDA’s Recent Combination Drug Product Guidance: Applications to DPIs, pMDIs, and Nasal Sprays” will be presented by Badre Hammond, Associate Director, Market Development Aptar Pharma Prescription and Wendy Bolf, Regulatory Affairs

Manager, Aptar Pharma Prescription. This seminar will give insights on optimal approaches to help secure approval in this changing and challenging regulatory landscape and will specifically address the following topics:

  • The Basics – medical device, combination product and packaging components
  • NDA/ANDA submissions: regulatory pathway review for combination products
  • Human Factor studies in the context of combination product
  • Clarify expectations: Sponsor, device supplier and regulators

Aptar Pharma’s Platinum Sponsor Seminar will take place twice on Tuesday, April 24 in Tucson Room I and J, at 8:00 AM and again 8:45 AM, ensuring delegates have the greatest opportunity to attend their preferred time slot.

In addition to presenting at RDD 2018, Aptar Pharma will be hosting an interactive table, located in the Arizona Ballroom, where their team of experts will showcase their innovative range of MDIs, DPIs and BAIs, and demonstrate how they can accelerate speed-to-market by assisting customers from concept through to regulatory submission and approval.

The Aptar Pharma table will also feature a Connectivity Focus, dedicated to the growing field of c-Devices, offering insight into their range of add-on and integrated cDevices. These intuitive devices feature fully-connected functionality and software integration to improve patient health outcomes.

To connect with Aptar Pharma at RDD 2018 and meet their team of experts, register at: http://www.rddonline.com/registration.

About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America.

For more information, visit: www.aptar.com/pharma.

About RDD Online

RDD Online manages the organization of Respiratory Drug Delivery meetings in the US, and partners with Aptar Pharma to run RDD meetings in Europe and Asia.

Other RDD Online services available at www.rddonline.com include the provision of scientific and technical publications, aerosol testing equipment including dose collection tubes and mixing inlets, web-based training, textbook publishing, service directories and recruiting services of interest to companies active in pulmonary and nasal drug delivery. For more information, please visit: www.rddonline.com.

Resources

Click on Aptar Pharma Showcases Connected Devices at RDD for other information.
Click on
Aptar Pharma to contact the company directly.

a1

Supplier Information
Supplier: Aptar Pharma
Address: Aptar Radolfzell GmbH, Oeschlestrasse 54-56, 78315 Radolfzell, Germany
Tel: +49 7732 801 0
Fax: +49 7732 801 226
Website: www.aptar.com


Comments are closed.